Home
Search
BIO International Convention   |   June 16-19, 2025

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Karin Hoelzer, DVM, PhD
SENIOR DIRECTOR, POLICY AND REGULATORY AFFAIRS, NATIONAL ORGANIZATION FOR RARE DISORDERS (NORD)
40 years of the Orphan Drug Act, the Rare Disease Endpoint Advancement (RDEA) Pilot Program, and Transforming Rare Disease Development
Vera Hoffman, MBA
CEO, REVEAL PHARMA
Reveal Pharma
Cambridge, Massachusetts, United States
Michael Holmes
CSO, TESSERA THERAPEUTICS
The Next Generation of Gene Editing Therapeutic Technologies
Wang Hongwei
VICE PRESIDENT, ONCOLOGY GLOBAL DEVELOPMENT, BEIGENE
Patient Diversity and Beyond: Tapping the Potential of the Asia Pacific for Clinical Trials
Joshua Hooks
AAAS FELLOW, NATIONAL INSTITUTE OF AGING
NIH Efforts for Supporting Small Business Entrepreneurs from Diverse Backgrounds
Chris Houchens, PhD
DIRECTOR DIVISION CBRN MCMS, BARDA
Sustainable Innovation: Addressing 21st Century Health Security Threats (DoD/ASPR Engagement Day)
Tackling the Global Challenge of Antimicrobial Resistance: What Will It Take?
Placeholder Photo
Dan Housman, BA
CEO, COURAGE THERAPEUTICS
Courage Therapeutics
Newton, Massachusetts, United States
Laura Housman
MANAGING DIRECTOR, EVIDENCE & STRATEGY, AVALERE / FISHAWACK HEALTH
Prescient Diagnostics: Implications for Product Development and Reimbursement
Angelita Howard
ASSISTANT DEAN OF ONLINE EDUCATION, MOREHOUSE SCHOOL OF MEDICINE
Creating Higher Educational Pipelines in Biotechnology that Addresses Diversity, Equity, and Inclusion
Atlanta, Georgia, United States
Paul Howard, PhD
SENIOR DIRECTOR OF PUBLIC POLICY, AMICUS THERAPEUTICS
Student Day Welcome & Session
PDUFA VII and Beyond: Building Confidence in AI Tools as New “Gold Standards” for Drug Development
Philidelphia, Pennsylvania, United States